205 related articles for article (PubMed ID: 35467036)
21. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
22. Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells.
Deng Y; Wu S; Yang Y; Meng M; Chen X; Chen S; Li L; Gao Y; Cai Y; Imani S; Chen B; Li S; Deng Y; Li X
Front Immunol; 2020; 11():802. PubMed ID: 32431711
[TBL] [Abstract][Full Text] [Related]
23. New insights into ILC2 memory.
Martinez-Gonzalez I; Takei F
Immunol Rev; 2024 May; 323(1):118-125. PubMed ID: 38506432
[TBL] [Abstract][Full Text] [Related]
24. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
[TBL] [Abstract][Full Text] [Related]
25. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
26. NRP1 downregulation correlates with enhanced ILC2 responses during IL-33 challenge.
Wang Y; Liu G; Wang J; Zhou P; Zhang L; Liu Q; Zhou J
Immunology; 2024 Jun; 172(2):226-234. PubMed ID: 38409805
[TBL] [Abstract][Full Text] [Related]
27. Regnase-1 degradation is crucial for IL-33- and IL-25-mediated ILC2 activation.
Matsushita K; Tanaka H; Yasuda K; Adachi T; Fukuoka A; Akasaki S; Koida A; Kuroda E; Akira S; Yoshimoto T
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31990689
[TBL] [Abstract][Full Text] [Related]
28. The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2.
Zook EC; Ramirez K; Guo X; van der Voort G; Sigvardsson M; Svensson EC; Fu YX; Kee BL
J Exp Med; 2016 May; 213(5):687-96. PubMed ID: 27069114
[TBL] [Abstract][Full Text] [Related]
29. SLC7A8 is a key amino acids supplier for the metabolic programs that sustain homeostasis and activation of type 2 innate lymphoid cells.
Panda SK; Kim DH; Desai P; Rodrigues PF; Sudan R; Gilfillan S; Cella M; Van Dyken SJ; Colonna M
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2215528119. PubMed ID: 36343258
[TBL] [Abstract][Full Text] [Related]
30. Birch pollen-specific subcutaneous immunotherapy reduces ILC2 frequency but does not suppress IL-33 in mice.
van Rijt LS; Logiantara A; Canbaz D; van Ree R
Clin Exp Allergy; 2018 Nov; 48(11):1402-1411. PubMed ID: 30126007
[TBL] [Abstract][Full Text] [Related]
31. IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus.
Bartemes K; Chen CC; Iijima K; Drake L; Kita H
J Immunol; 2018 Jan; 200(1):229-236. PubMed ID: 29133293
[TBL] [Abstract][Full Text] [Related]
32. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
33. Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cells.
Su HH; Cheng CM; Yang YN; Chang YW; Li CY; Wu ST; Lin CC; Wu HE; Suen JL
Mucosal Immunol; 2024 Feb; 17(1):13-24. PubMed ID: 37805143
[TBL] [Abstract][Full Text] [Related]
34. Optimal identification of human conventional and nonconventional (CRTH2
Liu S; Sirohi K; Verma M; McKay J; Michalec L; Sripada A; Danhorn T; Rollins D; Good J; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2020 Aug; 146(2):390-405. PubMed ID: 32032632
[TBL] [Abstract][Full Text] [Related]
35. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
Salimi M; Barlow JL; Saunders SP; Xue L; Gutowska-Owsiak D; Wang X; Huang LC; Johnson D; Scanlon ST; McKenzie AN; Fallon PG; Ogg GS
J Exp Med; 2013 Dec; 210(13):2939-50. PubMed ID: 24323357
[TBL] [Abstract][Full Text] [Related]
36. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
Drake LY; Iijima K; Kita H
Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
[TBL] [Abstract][Full Text] [Related]
37. Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period.
Steer CA; Mathä L; Shim H; Takei F
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573494
[TBL] [Abstract][Full Text] [Related]
38. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
39. IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow.
Stier MT; Zhang J; Goleniewska K; Cephus JY; Rusznak M; Wu L; Van Kaer L; Zhou B; Newcomb DC; Peebles RS
J Exp Med; 2018 Jan; 215(1):263-281. PubMed ID: 29222107
[TBL] [Abstract][Full Text] [Related]
40. ICOS promotes group 2 innate lymphoid cell activation in lungs.
Kamachi F; Isshiki T; Harada N; Akiba H; Miyake S
Biochem Biophys Res Commun; 2015 Aug; 463(4):739-45. PubMed ID: 26049110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
